Tessera Therapeutics Announces R&D Collaboration with Cystic Fibrosis Foundation
Tessera’s Gene WritingTM Technology is Designed to Simultaneously Correct Multiple Genetic Mutations as well as to Write Genes in Their...
Tessera Therapeutics Announces R&D Collaboration with Cystic Fibrosis Foundation
Laronde banks $440M to ramp up RNA-based meds that could turn cells into protein factories
Neumora Therapeutics Launches to Pioneer a New Era of Precision Medicines for Brain Diseases
eFFECTOR Therapeutics Debuts as Publicly Traded Next-Generation Oncology Company
BiotechBayer bets $1.5B that Vividion will help it target the 'undruggable' and make 1+1=3
Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform
Pacific Biosciences Signs Definitive Agreement to Acquire Omniome
Vividion Therapeutics Files for IPO
Tempest and Millendo Announce Stockholder Approval of Merger